Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL

Conditions: Large B-cell Lymphoma; Relapsed Non-Hodgkin Lymphoma Interventions: Radiation: Comprehensive Ablative Bridging Irradiation (CABI); Biological: Chimeric Antigen Receptor T-Cell Therapy Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Kite, A Gilead Company Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials